Evidence is improving for management of this extra-rare autoimmune disease in kids
Care is evolving to address aspects patients care about, side effects and fatigue
Cell-based therapies, broader B-cell targeting, and immune tolerance are all in the works
A spate of new approvals set off a "revolution" in management
